Important Tax Note: Portfolia has delivered all K-1s before the March 15th deadline as we do every year. As always, these documents were sent through an encrypted email to protect your information from admin@moonstonecpa.com. For any questions or issues accessing your documents, please email members@portfolia.com.
Annual Fund Performance Report
EIN: 86-3587637
2026 Fund Performance Overview Session
The fund partners shared an overview of the fund's performance, current updates on all companies, and discussed how they're viewing the market.
2025 Rising America II Fund Performance Report
The 2025 financial statements are as of and for December 31, 2025. Please note all updates provided are confidential and not for distribution.
To access the file, use password:
2025RA2Report!
Semi-Annual Company Reports
The EOY highlights 2025 as provided by the companies are linked below. Please note all updates provided are confidential and not for distribution.
To access the file, use password: EOY25RA2!
Rising America II Portfolio Highlights
The Portfolia Rising America Fund II builds on the successful investment model of the first fund and will continue to invest directly in early-stage and growth companies in the US where we see opportunities for returns and market impact in emerging markets.
The dashboard is where our innovative model of collaborative, transparent investing comes to life. Your dashboard will provide detailed company information (i.e. company updates, companies in diligence, new investments), recordings of company pitches, and links for upcoming events.
Portfolio Company Valuations
The Companies & Leadership Team
The Portfolia Rising America Fund II is led by a world-class team of highly sophisticated and experienced investors who are leaders in their respective fields, as venture capitalists, angel investors, and innovators. They bring an expert skill-set including sourcing, diligence, deal negotiation, executive recruitment, strategy and governance. Click on photos for full bios.
The Companies
Portfolia Fund Partners
Interested in other funds?
Connect with Investor Relations at investorrelations@portfolia.com
Additional questions?
Reach out to our team at members@portfolia.com
Developer of a medical device designed to help control nosebleeds in children and adults.